Return to search

Circle Pharma grabs $45m Series B

South San Francisco-based Circle Pharma Inc, a macrocycle drug discovery and development company focused on intractable cancer targets, has raised $45 million in Series B financing.

South San Francisco-based Circle Pharma Inc, a macrocycle drug discovery and development company focused on intractable cancer targets, has raised $45 million in Series B financing. The Column Group led the round.

Source: Press Release